Handelsavisen
prelaunch
Companies Financials 1336.HK
13
1336.HK HKEX Life & Health Insurance

New China Life Insurance Co Ltd

HK$50,00
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
5,69 %
Op margin
ROE
6,8 %
Net margin
Debt / equity
0,34
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

New China Life Insurance Co Ltd provides life and health insurance products and services in China.

Business. New China Life Insurance Co Ltd (1336.HK) is a life and health insurance company headquartered in China. The firm operates within the Financials sector, specifically focusing on the Life & Health Insurance industry. It is primarily listed on the Hong Kong Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not provided.

Classification92 %
SectorFinancials
Business sectorInsurance
IndustryLife & Health Insurance
Generated · model-assisted
Sell-side consensus
HOLD15 analysts
5 buy5 hold5 sell
Avg 12m price target47,68

Analyst recommendations

15 analysts · consensus Hold
Buy5
Hold5
Sell5
12-month price target
47,68
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
15 analysts · indicative
Ownership
not yet wired
Profitability
6,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 1336.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 1336.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    New China Life Insurance Co Ltd (1336.HK) is a life and health insurance company headquartered in China. The firm operates within the Financials sector, specifically focusing on the Life & Health Insurance industry. It is primarily listed on the Hong Kong Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not provided.

    Classification92 %
    SectorFinancials
    Business sectorInsurance
    IndustryLife & Health Insurance
    AI synthesis
    GENERATED

    New China Life Insurance Co Ltd has a total equity of 90.03 billion CNY and a debt-to-equity ratio of 0.34, indicating a relatively conservative capital structure. The company's liquidity is assessed as medium, with a negative net cash position after subtracting total debt. Operating cash flow stands at 61.11 billion CNY, which supports its operational liquidity.

    The company's profitability is reflected in a return on equity (ROE) of 6.82% and a return on assets (ROA) of 0.41%. These figures are below the typical benchmarks for the insurance industry, suggesting that the company may not be generating returns as efficiently as its peers. The net income of 6.14 billion CNY and operating income of 6.8 billion CNY indicate a stable but modest profit margin.

    New China Life Insurance Co Ltd operates primarily in the Chinese market, with a significant portion of its revenue derived from domestic operations. The company's geographic exposure is concentrated, which may increase its vulnerability to local economic and regulatory changes. There is no detailed breakdown of revenue by business segment in the provided data.

    The company's growth trajectory is expected to remain stable, with no significant changes in revenue or profit margins anticipated in the near term. Capital expenditures are minimal, with a negative value of -732 million CNY, indicating that the company is not investing heavily in new assets. This suggests a focus on maintaining existing operations rather than expanding.

    The risk assessment for New China Life Insurance Co Ltd indicates a low potential for dilution, with no immediate pressure for share issuance. However, the company's liquidity risk is moderate, primarily due to its negative net cash position after accounting for total debt. Credit risk is not explicitly detailed in the provided data.

    Recent events and filings do not show any significant changes in the company's operations or financial strategy. Analysts have provided a range of price targets, with a mean of 47.68 CNY and a median of 48.50 CNY, indicating a generally positive outlook. The mean recommendation of 2.93 suggests a slight bias towards a hold or buy rating.

    Key takeaways
    • New China Life Insurance Co Ltd has a conservative capital structure with a debt-to-equity ratio of 0.34.
    • The company's return on equity is 6.82%, which is below typical industry benchmarks.
    • The company's liquidity is assessed as medium, with a negative net cash position after subtracting total debt.
    • Analysts have provided a range of price targets, with a mean of 47.68 CNY and a median of 48.50 CNY.
    • The company's growth trajectory is expected to remain stable, with no significant changes in revenue or profit margins anticipated in the near term.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2026-03-27
    FY 2026 · Full-year highlights

    Operating income +31,8% YoY; Net income +38,3% YoY.

    Revenue
    Operating income¥37.20B+31,8 % YoY
    Net income¥36.28B+38,3 % YoY
    Free cash flow¥24.29B+10,6 % YoY
    EPS
    Operating cash flow¥110.92B+15,2 % YoY
    Financials
    Income statement
    Revenue
    Gross profit
    Operating income¥37.20B
    Net income¥36.28B
    Balance sheet
    Total assets¥1.90T
    Total liabilities¥1.79T
    Total equity¥111.54B
    Cash & equivalents
    Long-term debt¥20.80B
    Cash flow
    Operating cash flow¥110.92B
    CapEx-¥1.48B
    Free cash flow¥24.29B
    SBC
    Highlights
    • Operating income +31,8% YoY
    • Net income +38,3% YoY
    • Free cash flow +10,6% YoY

    Valuation FY

    Market price
    HK$50,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    HK$90.03B
    Net cash
    -HK$30.97B
    Current ratio
    Debt / equity
    0.3
    ROA
    0.4%
    ROE
    6.8%
    Cash conversion
    995.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    8,46
    Predicted surprise
    -0,00
    Beat probability
    45 %
    Analysts
    15
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-01 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate8,46
    Revenueno estimateno estimate50,8B CNY
    Operating incomeno estimateno estimate31,9B CNY
    Full-year consensus mean (period as reported by source) · consensus in CNY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution15 analysts
    Strong buy2
    Buy3
    Hold5
    Sell4
    Strong sell1
    12-month price targetHK$47,68 · Median HK$48,50
    Low HK$37,00High HK$58,00
    Operating income · consensus31,9B CNY
    EPS surprise
    +37,4 %
    reported vs consensus · beat
    Revenue surprise
    −0,9 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowHK$37,00
    MeanHK$47,68
    MedianHK$48,50
    HighHK$58,00
    SpotHK$50,00
    −4.6 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    ROE6,8 %Above median
    D/E0,34Below median
    Cash Conv9,95Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • New China Life Insurance Co Ltd Market data — financials · 2026-05-26
    • New China Life Insurance Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    1336.HKCanonical
    HKEX · HKD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-03-27 16:48 UTCEARNINGSAnnual results — FY 2026 Net CNY 36.28B
    2025-03-27 15:00 UTCEARNINGSAnnual results — FY 2025 Net CNY 26.23B
    2024-03-27 16:27 UTCEARNINGSAnnual results — FY 2024 Net CNY 8.71B
    2023-03-30 14:51 UTCEARNINGSAnnual results — FY 2023 Net CNY 21.50B
    2022-03-29 14:13 UTCEARNINGSAnnual results — FY 2022 Net CNY 14.95B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage